Lab reportIn stockPT-141 10 mg
Lot PT141-092526-10Oct 22 2026
99.94%purity · HPLCILS Laboratories
- IdentityHPLC-RTMConfirmed
- ContentNet Peptide Content10.39 mg (labeled 10 mg)
- AppearanceVisualGood
99.94%
1025.16
189691-06-3
Short peptides
PT-141
A cyclic heptapeptide agonist at melanocortin receptors, principally MC3R and MC4R. Supplied as a reference ligand for melanocortin panels.
99.94% purity by HPLC, lot PT141-092526-10
$19.99$2.00 / mg
Lab results · 10 mg · lot PT141-092526-10
A 7-residue peptide, tested by an independent laboratory.
Each size is its own lot, tested before it is listed, and the laboratory’s report is published in full. The figure shows that report’s results for the size selected.
Short peptides7 residues10 mgLot PT141-092526-10
99.94%Purity, HPLCLot PT141-092526-10 · ILS Laboratories
1025.16Mass, DaNominal, for the parent compound
1Report publishedOne per size, as the laboratory issued it
Structure
The molecule, in three dimensions
C50H68N14O101025.16
Drag to turn
Residues · hover to locate
Every heavy atom is placed from the sequence with ideal bond lengths and angles, so the connectivity is exact. The pose is idealised, , and is not a measured conformation. Identity for each lot is reported on its lab report.
01 · Lab reports
One lot per size, each with its report
The results each laboratory report prints, with the laboratory’s own PDF. A report stays published after its lot sells out.
Lab reportIn stock1 of 1
02 · Lab results
What the report for this size shows
The results as printed on the laboratory’s report for the size selected above. The full report, with its chromatogram, is one click away.
03 · Sequence & identity
What is in the vial
Sequence
Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH
C50H68N14O10
Good
99.94%
04 · Sizes & pricing
Priced by the milligram
Each size is its own lot with its own lab report. The per-milligram figure puts every pack on the same basis.
Is the lab report for PT-141 public?
Yes. Each size is its own lot, tested by an independent laboratory, and the laboratory’s report is published in full in the COA Library as the PDF the laboratory issued. It stays published after the lot sells out.
How is the identity of PT-141 confirmed?
The laboratory reports identity for each lot, alongside purity by HPLC and the content of the vial. The report for each size is one click away.
How does a 10 mg vial relate to the price per milligram?
Each size is its own lot with its own lab report. The price per milligram is shown beside every size so packs can be compared on the same basis; larger fills carry a lower per-milligram price.
Is PT-141 supplied for human use?
No. PT-141 is supplied strictly for laboratory research use and is not for human consumption, veterinary use or any form of self-administration. Ordering requires an acknowledgement of this at checkout, and no dosing or administration information is provided anywhere on this site.
05 · Receiving & handling
Keep the lot as it was released
On arrival
Check, store
Match the lot number to the packing note, check the crimp seal and cake are intact, then store the sealed vial as the certificate directs.
Before opening
Equilibrate sealed
If the vial has been stored cold, let it reach room temperature while still closed. Opening a cold vial draws in moisture that condenses on the cake.
Keep a record
Lot and date
Log the lot number and the date each vial is opened. A tube without a lot number cannot be tied to a certificate. Handle under your own protocol - no dosing information is provided.
06 · Literature
Cited in full, summarised by nobody
Peer-reviewed papers on the compound, listed for bibliographic reference. Each entry is the title, journal, year and authors as published. We do not summarise findings, and nothing here is a claim about this material.
- 01An effect on the subjective sexual response in premenopausal women with sexual arousal disorder by bremelanotide (PT-141), a melanocortin receptor agonistJournal of Sexual Medicine · 2006 · Diamond LE, Earle DC, Heiman JR, et al.doi:10.1111/j.1743-6109.2006.00268.x
- 02Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 TrialsObstetrics and Gynecology · 2019 · Kingsberg SA, Clayton AH, Portman D, et al.doi:10.1097/AOG.0000000000003500
Related
Same molecular class
This compound’s certificate is public.
Read the full assay for the exact lot in stock before you order.